Verweij, E., Tura, A. K., Gure, T., Pyuza, J., Mchome, B., Kawaza, K., Moons, P., de Winter, D., van’t Oever, R., Spitalnik, S., van der Schoot, C. E., & van den Akker, T. (2024). Monoclonal RhD prophylaxis: high time to evaluate efficacy. The Lancet, 403(10429), 806–807. https://doi.org/10.1016/s0140-6736(23)01888-3